Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Acro Biomedical Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -1.09K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -1.32K% |
| December 31, 2021 | -644.3% |
| September 30, 2021 | |
| June 30, 2021 | -158.9% |
| March 31, 2021 | -59.80% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | 11.79% |
| December 31, 2019 | -39.22% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| September 30, 2018 | 6.39% |
| June 30, 2018 | 5.29% |
| March 31, 2018 | 3.54% |
| December 31, 2017 | 5.55% |
| September 30, 2017 | 7.75% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -38.74% |
| Xcelerate, Inc. | -- |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Vivos Therapeutics, Inc. | -107.2% |
| Stella Diagnostics, Inc. | -195.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -886.4% |
| Return on Net Operating Assets | -1.20K% |